Resources

Regional vulnerability in Huntington’s disease: fMRI-guided molecular analysis in patients and a mouse model of disease

Moreno H, Lewandowski N, Bordelon Y, Brickman A, Angulo S, Khan U, Muraskin J, Griffith E, Wasserman P, Menalled L,...

Resources

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington’s disease: zQ175

Menalled L, Kudwa A, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio B, McConnell K,...

Resources

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity .

S. Stefanie, H Bettina, Nilges M, Schroeder S, Hoelich A, Keletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M,...

Resources

Prediction of Death in the SMNΔ Mouse Model of Spinal Muscular Atrophy: Insight into Disease Stage and Progression. Journal of Neuroscience Methods.

El-Khodor BF, Cirillo K, Beltran JA, Mushlin R, Winberg ML, Charney R, Chomicova O, Marino T, Ramboz S.

Resources

Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Ä7 SMA KO Mouse Model of Spinal Muscular Atrophy.

Chen PC, Gaisina IN, El-Khodor BF, Ramboz S, Makhortova NR, Rubin LL, Kozikowski AP. ACS Chem Neurosci. 2012 Jan 18;3(1):5-11.

Resources

Effect of the rd1 mutation on motor performance in R6/2 and wild type mice. PLoS Currents Huntington Disease.

Menalled, L., El-Khodor, B. F., Hornberger, M., Park, L., Howland, D., and Brunner, D.

Resources

Behavior-Based Screening as an Approach to Polypharmacological Ligands, in Polypharmacology in Drug Discovery.

Brunner, D., Alexandrov, V., Caldarone, B., Hanania, T., Lowe, D., Schneider, J., and Chandrasekhar, J. (Peters, J.-U., Ed.), pp 301-309,...

Resources

R6/2 Huntington’s disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures.

Efrain Cepeda-Prado, Susanna Popp, Usman Khan, Dimitre Stefanov, Jorge Rodrguez, Liliana Menalled, Diana Dow-Edwards, Scott Small, and Herman Moreno JN-RM-0388-12R1

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started